期刊文献+

肌萎缩侧索硬化症药物治疗的研究进展 被引量:2

下载PDF
导出
摘要 肌萎缩侧索硬化症(ALS)是一种运动神经元的进行性变性疾病。其发病机制未明,目前缺乏特效治疗。我们对近年来药物:抗兴奋性氨基酸毒性、神经营养因子、抗凋亡、抗炎性类药物等治疗ALS的研究进展进行了综述。
作者 黄慧 张成
出处 《国际神经病学神经外科学杂志》 2006年第4期322-326,共5页 Journal of International Neurology and Neurosurgery
  • 相关文献

参考文献28

  • 1Kalra S,Tai P,Genge A,Arnold DL.Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging.J Neurol,2006 K[Epub ahead of print].
  • 2Saroff D,Delfs J,Kumetsov D,et al.Selective vulnerability of spinal cord motor neurons to non-NMDA toxicity.Neuroreport,2000,11(5):117-121.
  • 3Kanki R,Nakamizo T,Yamashita H,et al.Effects of mitochondrial dysfunction on glutamate receptor-mediated neurotoxicity in cultured rat spinal motor neurons.Brain Res,2004,1015(1-2):73-81.
  • 4Mazzini L,Mora G,Balzarini C,et al.The natural history and the effects of gabapentin in amyotrophic lateral sclerosis.J Neurol Sci,1998,160(Suppl 1):S57-63.
  • 5Miller RG,Moore D,Young LA,et al.Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis.WALS Study Group.Western Amyotrophic Lateral Sclerosis Study Group.Neurology,1996,47(6):1383-1388.
  • 6Kalra S,Cashman NR,Caramanos Z,et al.Gabapentin therapy for amyotrophic lateral sclerosis:lack of improvement in neuronal integrity shown by MR spectroscopy.AJNR Am J Neuroradiol,2003,24 (3):476-480.
  • 7Ryberg H,Askmark H,Persson LI.A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine:effects on CSF glutamate,aspartate,branched-chain amino acid levels and clinical parameters.Acta Neurol Scand,2003,108(1):1-8.
  • 8Rothstein JD,Patel S,Regan MR,et al.Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.Nature,2005,433(7021):73-77.
  • 9Ji HF,Shen L,Zhang HY.Beta-lactam antibiotics are multipotent agents to combat neurological diseases.Biochem Biophys Res Commun,2005,333(3):661-663.
  • 10Festoff BW.The preclinical rationale for the use of insulin-like growth factor-Ⅰ in amyotrophic lateral sclerosis.Drugs Today (Barc),1998,34(1):65-77.

同被引文献47

  • 1郁可,王庆松,李从阳,王俊,向阳.肌萎缩侧索硬化症患者抑郁状况调查及药物干预效果[J].脑与神经疾病杂志,2011,19(1):48-50. 被引量:5
  • 2Meininger V. ALS,what new 144 years after Charcot. ArchItal Biol, 2011 , 149 : 29-37.
  • 3Naganska E , Matyja E . Amyotrophic lateral sclerosis - lookingfor pathogenesis and effective therapy. Folia Neuropathol,2011, 49: 1-13.
  • 4Traynor BJ,Codd MB,Corr B,et al. Amyotrophic lateralsclerosis mimic syndromes : a population - based study. ArchNeurol, 2000, 57 : 109-113.
  • 5Logroscino G,Traynor BJ , Hardiman 0,et al. Incidence ofamyotrophic lateral sclerosis in Europe. J Neurol NeurosurgPsychiatry , 2010,81(4); 385-390.
  • 6Duffy JR,Peach RK,Strand EA. Progressive apraxia ofspeech as a sign of motor neuron disease . Am J Speech LangPathol, 2007 , 16(3 ) : 198-208.
  • 7Talbot K. Motor neuron disease : the bare essentials. PractNeurol, 2009 , 9(5 ) : 303-309.
  • 8Wijesekera LC,Mathers S,Talman P , et al. Natural historyand clinical features of the flail arm and flail leg ALS vari-ants .Neurology , 2009, 72: 1087-1094.
  • 9van Blitterswijk M,Landers JE. RNA processing pathways inamyotrophic lateral sclerosis. Neurogenetics, 2010, 11:275-290.
  • 10Renton AE,Majonnie E,Waite A , et al. A hexanucleotide re-peat expansion in C90RF72 is the cause of chromosome 9p21 -linked AI5-FTD. Neuron,2011,72(2) : 257-268.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部